A Phase III Study to Compare Melphalan, Prednisone, Lenalidomide (MPR) Versus Melphalan 200 Mg/m2 and Autologous Transplantation (MEL200) In Newly Diagnosed Multiple Myeloma Patients

Bibliographic Details
Title:	A Phase III Study to Compare Melphalan, Prednisone, Lenalidomide (MPR) Versus Melphalan 200 Mg/m2 and Autologous Transplantation (MEL200) In Newly Diagnosed Multiple Myeloma Patients
Authors:	Palumbo, Antonio, Cavallo, Federica ^, Hardan, Izhar ^, Ciccone, Giovannino ^, Larocca, Alessandra ^, Cavalli, Maide ^, Peccatori, Jacopo ^, Carella, Angelo Michele ^, Brioli, Annamaria ^, Cafro, Anna Maria ^, Patriarca, Francesca ^, Siniscalchi, Agostina ^, Pezzatti, Sara ^, Crippa, Claudia ^, Montefusco, ittorio, V ^, Levi, Anna ^, Ruggeri, Marina ^, Caravita, Tommaso ^, Yehuda, Dina Ben ^, Raimondo, Francesco Di ^, Boccadoro, Mario ^
Source:	In Blood 19 November 2010 116(21):3573-3573
Database:	ScienceDirect